Indian Biotech Database

News in the Life Sciences Industry
Results 61 - 80 out of 137 displayed.
« 1 2 3 4 5 6 7 »

Semaglutide 2.4 mg shows superior weight loss versus placebo in the phase 3 trials STEP 2 and STEP 3, thereby successfully completing the programme

By: GlobenewsWire - 12 Jun 2020

Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases

By: GlobenewsWire - 11 Jun 2020

TUV Rheinland issue first EU MDR certificate for Terumo Corporation

YOKOHAMA, Japan, June 10, 2020 /PRNewswire/ -- TUV Rheinland Japan Ltd. announced that on May 29, 2020 TUV Rheinland LGA Products GmbH issued TUV Rheinland's first MDR certificates under EU Medical Device Regulation 2017/745, for medical devices Terumo Corporation.

By: PR Newswire Association LLC. - 10 Jun 2020

Related companies: TÜV Rheinland AG | TUV Rheinland of North America, Inc. | TÜV Rheinland Nederland | TUV Rheinland India Pvt. Ltd.

Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies

SUZHOU, China, June 8, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced... Read more ››

By: PR Newswire Association LLC. - 09 Jun 2020

Sanofi to present Phase 3 results of avalglucosidase alfa in patients with late-onset Pompe disease

By: GlobenewsWire - 08 Jun 2020

Novo Nordisk reports weight loss of 14.9% (16.9% if taken as intended) in STEP 1 trial

By: GlobenewsWire - 04 Jun 2020

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 03 Jun 2020

Sanofi to launch “Action 2020”, a worldwide employee stock purchase plan

By: GlobenewsWire - 03 Jun 2020

European Commission approves Sarclisa® (isatuximab) for adults with relapsed and refractory multiple myeloma

By: GlobenewsWire - 02 Jun 2020

Sarclisa® (isatuximab) combination therapy demonstrated superior progression free survival and clinically meaningful depth of response in patients with relapsed multiple myeloma

By: GlobenewsWire - 02 Jun 2020

Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline

By: GlobenewsWire - 02 Jun 2020

Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma

SUZHOU, China, May 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT(R) (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma

SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced... Read more ››

By: PR Newswire Association LLC. - 01 Jun 2020

Sanofi announces closing of Regeneron stock sale

By: GlobenewsWire - 29 May 2020

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time

By: GlobenewsWire - 29 May 2020

Sanofi names new leaders to Executive Committee

By: GlobenewsWire - 29 May 2020

Sanofi’s Board of Directors notes the resignation of Emmanuel Babeau and coopts Gilles Schnepp as Independent Director

By: GlobenewsWire - 28 May 2020

Sanofi announces pricing of Regeneron stock offering

By: GlobenewsWire - 27 May 2020

Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

By: GlobenewsWire - 26 May 2020

Glenmark to Commence Another New Phase 3 Clinical Trial on a Combination of Two Anti-viral Drugs Favipiravir and Umifenovir in Hospitalized Patients of Moderate COVID-19 in India

MUMBAI, May 26, 2020 /PRNewswire/ -- Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced a new randomized, open-label study to test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19 treatment strategy.... Read more ››

By: PR Newswire Association LLC. - 26 May 2020

Related companies: Glenmark Pharmaceuticals Limited

« 1 2 3 4 5 6 7 »

Looking for companies outside of India?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

September 2020
- 20th Annual Biotech in Europe Forum
- US Eastern Daylight Time: BioPharm America™ 2020
- San Diego: Evolution Summit

See Events »

Add an Event »

Latest company news

Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Principia Biopharma Inc.
22 Sep 2020 (GlobenewsWire)

Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply
22 Sep 2020 (PR Newswire Association LLC.)

BioLife Sciences (BLFE) Announces Distribution Agreement With BeMotion Inc.
21 Sep 2020 (GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of India?

Partners

Upcoming Life Sciences Events

Latest company news